Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-13
2005-09-13
Shah, Mukund J. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S009000, C544S012000
Reexamination Certificate
active
06943159
ABSTRACT:
The invention provides novel compounds represented by general formula (I)wherein the bond represented by the broken line may be a single, double bond or absent; and if the bond is absent, then the nitrogen is substituted with a hydrogen and R2; X represents SO2or C═O of CH2; Y represents —CH(R4)—, —N(R4)—CH2—, O; and the meaning of R2, R3, R4, R5, R6, R7, and R8are as defined in the application. The compounds are useful as positive modulators of the AMPA-receptor.
REFERENCES:
patent: 3275625 (1966-09-01), Müller et al.
patent: 3277086 (1966-10-01), Wei et al.
patent: 3311620 (1967-03-01), Bell et al.
patent: 3351595 (1967-11-01), de Stevens et al.
patent: 3419552 (1968-12-01), Whitehead et al.
patent: 3639342 (1972-02-01), Miyadera et al.
patent: 3969518 (1976-07-01), Novello
patent: 4184039 (1980-01-01), Soldati et al.
patent: 5488049 (1996-01-01), Costa et al.
patent: 5536719 (1996-07-01), Cordi et al.
patent: 6015800 (2000-01-01), Nikam
patent: 6083947 (2000-07-01), Granger et al.
patent: 1125938 (1962-03-01), None
patent: 147316 (1969-04-01), None
patent: 1470316 (1969-04-01), None
patent: 0692484 (1996-01-01), None
patent: 861367 (1961-02-01), None
patent: 863474 (1961-03-01), None
patent: 946864 (1964-01-01), None
patent: 1049322 (1966-11-01), None
patent: 176232 (1981-01-01), None
patent: 296964 (1965-05-01), None
patent: WO 9321170 (1993-10-01), None
patent: WO 9321171 (1993-10-01), None
patent: WO 9515759 (1995-06-01), None
patent: WO 9638414 (1996-12-01), None
patent: WO 9707799 (1997-03-01), None
patent: WO 9726884 (1997-07-01), None
patent: WO 9736907 (1997-10-01), None
patent: WO 9749692 (1997-12-01), None
patent: WO 9812185 (1998-03-01), None
CAS printout for Orita et al. Chem. Abs. 99:169045.
CAS printout for Di et al. Chem. Abs. 88: 145975.
CAS printout for Abramovitch et al. Chem. Abs. 87:117236.
CAS printout for Ghelardoni et al. Chem. Abs. 68:12959 and Chem. Abs. 67:108649.
CAS printout for Werner et al. Chem Abs CA54:12148g.
Werner et al. Dihydrobenzothiadiazine 1,1-dioxides and their diuretic properties, 1960, Chem Abs CA54:12148g.
Gay, “Bendrofluazide Assay Including Extractive Alkylation for GC,” Methodol. Surv. Biochem., 1978, pp. 133-139, No. 7.
Topliss et al.,Journal of Medicinal Chemistry, vol. 15, No. 4, pp. 400-403 (1972).
Imai et al.,Communications, pp. 851-852 (Oct. 1983).
Liang et al.,Journal, 3074475, YHHPAL; Yaoxue Xebao; 10; 1963; 345-354;Chem. Abstr; 59; 13985; 1963.
Foeldi et al.,Journal, 2700364, ACASA2;Acta Chim. Acad. Sci. Hung.; 38; 1963; 147.
E. Marchetti et al.,Journal, 22139, BCFAAI;Boll. Chim. Farm.; IT; 104; 1965.
Alo et al.,J. Chem. Soc. Perkin Trans., No. 5, pp. 805-808 (1986).
Martin et al.,Journal of the Chemica Society, pp.2451-2458 (1974).
Raffa et al.,Cardiovascular Acitivity of 1,2,4-benzothiadiazine 1,1-dio, Farmaco, Ed. Sci, vol. 29, No. 9, XP002107961, pp.647-653 (1974).
Ghelardoni et al.,Hydrogenolysis of 3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxides. VII, Ann. Chim.(Rome), vol. 62, No. 5, XP002107962, pp. 373-384 (1972).
Wales et al.,The Journal of Pharmacology and Experimental Therapeutics, vol. 164, No. 2, pp. 421-432 (1968).
Yale,The Journal of Organic Chemistry, vol. 33, No. 6, pp.2382-2385 (Jun. 1968).
Bierbaum et al.,Journal of Medicinal Chemistry, vol. 6, pp.272-275 (1963).
Kirkien-Rzseszotarski et al.,Journal of Heterocyclic Chemistry, vol. 12, No. 1, pp. 155-159 (Feb. 1975).
Ghelardoni et al.,Ann Chim(Rome),Hydrogenolysis of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides. V, vol. 58, pp. 1402-1415, XP002107967 (1968).
Loynes et al.,Journal of Medicinal Chemistry, vol. 8, pp.691-694 (Mar. 9, 1965).
Short et al.,Journal of Organic Chemistry, vol. 26, pp.3428-3431 (Sep., 1961).
Ghelardoni et al.,Ann. chim.(Rome), vol. 54, pp.449-461, XP002107969 (1964).
Topliss et al.,Journal of Organic Chemistry, vol. 26, pp.3842-3850 (Oct. 1961).
Bernabei et al.,Farmaco, Ed. Sci., vol. 31, No. 7, XP002107959, pp.508-516 (1976).
Gouliaev Alex Haahr
Johansen Tina Holm
Larsen Mogens
Mathiesen Claus
Nielsen Elsebet Østergaard
Birch Stewart Kolasch & Birch, LLP.
Liu Hong
Neurosearch A/S
Shah Mukund J.
LandOfFree
Compounds and their use as positive AMPA receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and their use as positive AMPA receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their use as positive AMPA receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3440298